ERYTECH to Present Preclinical Results Supporting Immunotherapy Potential of ERYMMUNE Platform at Two … – Business Wire (press release)
|
ERYTECH to Present Preclinical Results Supporting Immunotherapy Potential of ERYMMUNE Platform at Two …
Business Wire (press release) These data support the therapeutic strategy of using red blood cells as carriers to induce efficient and antigen-specific immune response for effective cancer immunotherapy, suggesting that this platform has immense potential in cancer immunotherapy … |
